Alomfilimab

DB16681InvestigationalProtein Based Therapies

Alomfilimab is under investigation in clinical trial NCT03829501 (Safety and Efficacy of KY1044 and Atezolizumab in Advanced Cancer).

Mechanism: Pharmacologically active on Inducible T-cell costimulator
Curator reviewed
Code names: KY-1044

Resolves to

Compound

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Alomfilimab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.